Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Avient
AVNT
$4.25B
| $7.62M | ﹤0.01% |
175,142
-24,311
| -12% | -$1.07M |
|
1877
Matsons
MATX
$6.5B
| $7.62M | ﹤0.01% |
255,276
-18,434
| -7% | -$521K |
|
|
AKS
1878
PUT
DELISTED
AK Steel Holding Corp
AKS
| $7.62M | ﹤0.01% |
1,345,700
+689,800
| +105% | +$3.6M |
|
|
ORIG
1879
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
| $7.61M | ﹤0.01% |
+283,816
| New | +$7.21M |
|
|
HTZ
1880
PUT
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $7.58M | ﹤0.01% |
395,023
+254,716
| +182% | +$4.92M |
|
1881
Dorman Products
DORM
$4.05B
| $7.57M | ﹤0.01% |
123,745
+101,190
| +449% | +$6.86M |
|
|
OCLR
1882
PUT
DELISTED
Oclaro Inc.
OCLR
| $7.56M | ﹤0.01% |
1,122,100
+985,300
| +720% | +$7.28M |
|
1883
Travere Therapeutics
TVTX
$5.86B
| $7.55M | ﹤0.01% |
358,283
-52,554
| -13% | -$1.2M |
|
1884
PUT
SBA Communications
SBAC
$19.6B
| $7.55M | ﹤0.01% |
46,200
+26,500
| +135% | +$4.21M |
|
|
SAGE
1885
CALL
DELISTED
Sage Therapeutics
SAGE
| $7.54M | ﹤0.01% |
45,800
+12,700
| +38% | +$1.23M |
|
1886
Werner Enterprises
WERN
$2.33B
| $7.52M | ﹤0.01% |
194,501
+74,669
| +62% | +$2.71M |
|
1887
CALL
Sarepta Therapeutics
SRPT
$1.91B
| $7.52M | ﹤0.01% |
135,100
| – | – |
|
1888
Dentsply Sirona
XRAY
$2.31B
| $7.5M | ﹤0.01% |
113,944
-1,925,099
| -94% | -$122M |
|
1889
CALL
Shake Shack
SHAK
$3.02B
| $7.47M | ﹤0.01% |
172,900
+83,000
| +92% | +$3.22M |
|
1890
A.O. Smith
AOS
$8.45B
| $7.46M | ﹤0.01% |
121,818
-353,912
| -74% | -$21.5M |
|
|
1891
PUT
Shake Shack
SHAK
$3.02B
| $7.46M | ﹤0.01% |
172,700
+9,000
| +5% | +$349K |
|
|
GRA
1892
PUT
DELISTED
W.R. Grace & Co.
GRA
| $7.45M | ﹤0.01% |
106,200
+53,900
| +103% | +$3.9M |
|
1893
CALL
Trinity Industries
TRN
$2.36B
| $7.43M | ﹤0.01% |
275,578
+32,086
| +13% | +$800K |
|
|
HTZ
1894
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $7.43M | ﹤0.01% |
386,986
+299,879
| +344% | +$5.8M |
|
1895
CALL
United States Natural Gas Fund
UNG
$487M
| $7.41M | ﹤0.01% |
79,456
+37,862
| +91% | +$3.66M |
|
1896
PUT
Dover
DOV
$27.9B
| $7.4M | ﹤0.01% |
90,745
-38,997
| -30% | -$3.02M |
|
|
DFS
1897
CALL
DELISTED
Discover Financial Services
DFS
| $7.4M | ﹤0.01% |
96,200
-9,700
| -9% | -$667K |
|
1898
iShares China Large-Cap ETF
FXI
$4.16B
| $7.38M | ﹤0.01% |
159,768
-115,557
| -42% | -$5.33M |
|
1899
CALL
CarMax
KMX
$8.5B
| $7.38M | ﹤0.01% |
115,000
-37,300
| -24% | -$2.66M |
|
1900
CALL
Fortinet
FTNT
$117B
| $7.37M | ﹤0.01% |
843,500
+520,500
| +161% | +$4.24M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.